GnRH agonists: increased risk of fracture in men with prostate cancer

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2001年 / 867卷 / 1期
关键词：
Prostate Cancer; Bone Turnover; Hypogonadism; Bone Mineral Density Measurement; GnRH Agonist;
D O I：
10.2165/00128415-200108670-00008
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [21] Qualitative Analysis of Interviews and Focus Groups Exploring Factors Contributing to Adherence to GnRH Agonists in Men with Prostate Cancer
    George, Gincy
    Rudman, Sarah
    Fleure, Louisa
    Moon, Zoe
    Garmo, Hans
    Cahill, Fidelma
    Fox, Louis
    Moss, Charlotte
    Wylie, Harriet
    Haire, Anna
    Van Hemelrijck, Mieke
    SEMINARS IN ONCOLOGY NURSING, 2022, 38 (04)
  • [22] Gonadotropin-releasing hormone agonists and fracture risk: A claims-based cohort study of men with nonmetastatic prostate cancer
    Smith, MR
    Lee, WC
    Brandman, J
    Wang, Q
    Botteman, M
    Pashos, CL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 7897 - 7903
  • [23] Fracture Risk in Men With Prostate Cancer: A Population-Based Study
    Melton, L. Joseph, III
    Lieber, Michael M.
    Atkinson, Elizabeth J.
    Achenbach, Sara J.
    Zincke, Horst
    Therneau, Terry M.
    Khosla, Sundeep
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (08) : 1808 - 1815
  • [24] Baseline fracture risk in men with prostate cancer starting the STAMPEDE trial
    Brown, J. E.
    Handforth, C.
    Walsh, J.
    Pezaro, C.
    Sydes, M. R.
    Clarke, N. W.
    James, N. D.
    McCloskey, E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [25] Fracture risk in Danish men with prostate cancer: a nationwide register study
    Abrahamsen, Bo
    Nielsen, Morten F.
    Eskildsen, Peter
    Andersen, Jens Thorup
    Walter, Steen
    Brixen, Kim
    BJU INTERNATIONAL, 2007, 100 (04) : 749 - 754
  • [26] GnRH agonists: risk of major CV events incurring increased costs
    Reactions Weekly, 2020, 1833 (1) : 6 - 6
  • [27] Increased Inflammatory Potential of Diet is Associated with Increased Risk of Prostate Cancer in Iranian Men
    Shivappa, Nitin
    Hebert, James R.
    Askari, Faezeh
    Parizi, Mehdi Kardoust
    Rashidkhani, Bahram
    INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2016, 86 (5-6) : 161 - 168
  • [28] A systematic review and meta-analysis of cardiovascular disease risk with degarelix and GnRH agonists in prostate cancer
    de Moraes, Francisco Cezar Aquino
    Sano, Vitor Kendi Tsuchiya
    Dantas, Clara Rocha
    Hoffmeister, Nathalia
    Kelly, Francinny Alves
    Burbano, Rommel Mario Rodriguez
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [29] The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: An unresolved controversy
    Conteduca, Vincenza
    Di Lorenzo, Giuseppe
    Tartarone, Alfredo
    Aieta, Michele
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 86 (01) : 42 - 51
  • [30] Assessment of glucose metabolic disorders in management of prostate cancer with GnRH agonists
    Gritskevich, E.
    Demidova, T.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 336 - 336
12345